Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
4.060
+0.010 (0.25%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Bionano Genomics Employees
Bionano Genomics had 344 employees as of December 31, 2023. The number of employees decreased by 61 or -15.06% compared to the previous year.
Employees
344
Change (1Y)
-61
Growth (1Y)
-15.06%
Revenue / Employee
$89,465
Profits / Employee
-$325,631
Market Cap
12.18M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
BNGO News
- 10 days ago - Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - GlobeNewsWire
- 18 days ago - Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 - GlobeNewsWire
- 25 days ago - Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect - GlobeNewsWire
- 4 weeks ago - Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting - GlobeNewsWire
- 5 weeks ago - Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025 - GlobeNewsWire
- 5 weeks ago - Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML - GlobeNewsWire
- 3 months ago - Bionano Announces Effective Date of Reverse Stock Split - GlobeNewsWire